Key result
Perioperative cefazolin shows non-inferiority to cefuroxime for preventing surgical site infections.
Why the study?
The study was conducted to compare the risk of surgical site infections in intra-abdominal infections without sepsis following the implementation of a guideline setting cefazolin instead of cefuroxime as standard perioperative antibiotic prophylaxis.
Does cefazolin prevent surgical site infections as effectively as cefuroxime in patients undergoing emergency surgery for intra-abdominal infections without sepsis?
Observational (n=392)
No
Does cefazolin prevent surgical site infections as effectively as cefuroxime in patients undergoing emergency surgery for intra-abdominal infections without sepsis?
Cefazolin appears non-inferior to cefuroxime for preventing surgical site infections in intra-abdominal infections without sepsis, though it may increase the risk of other postoperative infections.
Answers are grounded in this paper and cite their sources.
Cefazolin may be non-inferior for SSI prevention in this cohort; leaves open confirmation by randomized trials before practice change.
Background: The adequate choice of perioperative antibiotic prophylaxis (PAP) could influence the risk of surgical site infections (SSIs) in general surgery. A new local PAP guideline was implemented in May 2017 and set the first-generation cefazolin (CFZ) instead the second-generation cefuroxime (CXM) as the new standard prophylactic antibiotic. The aim of this study was to compare the risk of SSIs after this implementation in intra-abdominal infections (IAIs) without sepsis. Methods: We performed a single center-quality improvement study at a 1500 bed sized university hospital in Germany analyzing patients after emergency surgery during 2016 to 2019 (n = 985), of which patients receiving CXM or CFZ were selected (n = 587). Propensity score matching was performed to ensure a comparable risk of SSIs in both groups. None-inferiority margin for SSIs was defined as 8% vs. 4%. Results: Two matched cohorts with respectively 196 patients were compared. The rate of SSIs was higher in the CFZ group (7.1% vs. 3.6%, p = 0.117) below the non-inferiority margin. The rate of other postoperative infections was significantly higher in the CFZ group (2.0% vs. 8.7%, p = 0.004). No other differences including postoperative morbidity, mortality or length-of-stay were observed. Conclusion: Perioperative antibiotic prophylaxis might be safely maintained by CFZ even in the treatment of intra-abdominal infections.
No takes yet. Share an insight, caveat, or question.
Surat et al. (2022) conducted an observational in Intra-abdominal infections without sepsis (n=392). Cefazolin vs. Cefuroxime was evaluated on Surgical site infections (SSIs) (p=0.117). Perioperative prophylaxis with cefazolin resulted in a surgical site infection rate of for cefuroxime, remaining below the predefined non-inferiority margin.
Synapse has enriched 10 related papers. Consider them for comparative context: